Chemicals & Advanced Materials Global On demand · 24-48h

Global Glycyrrhiza Inflata Root Extract Market Strategic Research Report

Global Glycyrrhiza Inflata Root Extract Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Glycyrrhiza Inflata Root Extract Market
$2542025
6.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Pharmaceutical Grade, Food Grade, Feed Grade, Others

By Application: Food Industry, Cosmetic Industry, Pharmaceutical Industry, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Xinjiang Long Hui Yuan Pharmaceutical Co., Ltd. (CN), Qinghai Beili Licorice Science and Technology Co., Ltd. (CN), Gansu Fanzhi Pharmaceutical Co., Ltd. (CN), Zhangjiagang Free Trade Zone Hongyufeng Biotechnology Co., Ltd. (CN), Agrolic Impex (UZ), Sepidan Osareh (IR), F&C Licorice (IS), Norevo GmbH (DE), Ransom Naturals (UK), Zagros Licorice (IR), Mafco Worldwide (US), Maruzen Pharmaceuticals (JP), Aushadhi Herbal (IN), VPL Chemicals (IN)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 125 pages
Market size 2025
$254
Million USD
Forecast CAGR
6.5%
2025-2032
Forecast 2032
$394.7
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Glycyrrhiza Inflata Root Extract market size is predicted to grow from US$ 254 million in 2025 to US$ 391 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

In 2025, global sales volume of Glycyrrhiza inflata root extract reached 12,000 metric tons, with an average price of US$20,863 per ton.

Glycyrrhiza inflata root extract (INCI name: Glycyrrhiza inflata Root Extract) is a natural plant extract obtained from the dried roots and rhizomes of the legume Glycyrrhiza inflata Batalin through processes such as water, alcohol, or solvent extraction. Rich in various bioactive components—primarily glycyrrhizin, licochalcone A (LCA), glycyrrhetinic acid, flavonoids (such as liquiritigenin and isoliquiritigenin), and triterpene saponins—the extract offers multiple benefits, including significant anti-inflammatory, antioxidant, antibacterial, and anti-tumor properties, as well as sun protection and skin-whitening effects.

The raw material for this extract consists of the dried roots and rhizomes of Glycyrrhiza inflata, a perennial herbaceous plant of the Fabaceae (legume) family. It is primarily distributed across southern Xinjiang, China (including the Tarim Basin, Aksu, Bayingolin, and Hotan regions) and western Gansu (such as Jiuquan and Dunhuang), as well as in Central Asian countries like Kazakhstan and Uzbekistan. Among the three licorice species recognized in pharmacopoeias, Glycyrrhiza inflata exhibits the highest stress tolerance; it can withstand soil salinity levels up to 20% (with an optimal range of 2%–4%) and demonstrates exceptional drought resistance, thriving in areas with annual precipitation of less than 100 mm. Its roots and rhizomes are robust, gray-brown or grayish-tan in color, hard in texture, and low in starchiness, with a taste that is sweet or slightly bitter. In 2025, Glycyrrhiza inflata (inflated-fruit licorice) accounts for 13% of the total licorice cultivation area in Xinjiang; wild populations are primarily concentrated along the Tarim River in southern Xinjiang. Due to its inclusion in China's list of key protected wild medicinal materials—which strictly limits the harvesting of wild resources—current cultivation is dominated by Glycyrrhiza uralensis (Ural licorice). Large-scale cultivation dedicated specifically to Glycyrrhiza inflata remains limited, and the stability of raw material supply is a critical bottleneck constraining the expansion of production capacity.

The cost structure for Glycyrrhiza inflata root extract comprises raw material procurement (approx. 35%–45%), extraction and processing (approx. 25%–35%), quality testing and standardization (approx. 10%–15%), packaging and logistics (approx. 8%–12%), and R&D and compliance costs (approx. 5%–10%).

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glycyrrhiza Inflata Root Extract market?

What factors are driving Glycyrrhiza Inflata Root Extract market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glycyrrhiza Inflata Root Extract market opportunities vary by end market size?

How does Glycyrrhiza Inflata Root Extract break out by Type, by Application?

This report presents a comprehensive overview of the global Glycyrrhiza Inflata Root Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Pharmaceutical Grade
  • Food Grade
  • Feed Grade
  • Others

Segment by Product Form

  • Powder
  • Fluid Extract
  • Solid Extract Block
  • Other

Segment by Extraction Method

  • Solvent Extraction
  • Supercritical CO₂ Extraction
  • Ultrasonic-Assisted Extraction
  • Membrane Separation/Ceramic Membrane Ultrafiltration

Segment by Application

  • Food Industry
  • Cosmetic Industry
  • Pharmaceutical Industry
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Glycyrrhiza Inflata Root Extract market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Food Industry, Cosmetic Industry, Pharmaceutical Industry evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Glycyrrhiza Inflata Root Extract Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$254
2025
Forecast
$394.7
2032
CAGR
6.5%
2025–2032
Regiones
5
global
Key companies
Xinjiang Long Hui Yuan Pharmaceutical Co.Ltd. (CN)Qinghai Beili Licorice Science and Technology Co.Ltd. (CN)Gansu Fanzhi Pharmaceutical Co.Ltd. (CN)Zhangjiagang Free Trade Zone Hongyufeng Biotechnology Co.Ltd. (CN)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Pharmaceutical GradeFood GradeFeed GradeOthers
By Application
Food IndustryCosmetic IndustryPharmaceutical IndustryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Pharmaceutical Grade
  • 3.1.3 Food Grade
  • 3.1.4 Feed Grade
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Food Industry
  • 4.1.3 Cosmetic Industry
  • 4.1.4 Pharmaceutical Industry
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Xinjiang Long Hui Yuan Pharmaceutical Co., Ltd. (CN)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Qinghai Beili Licorice Science and Technology Co., Ltd. (CN)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Gansu Fanzhi Pharmaceutical Co., Ltd. (CN)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zhangjiagang Free Trade Zone Hongyufeng Biotechnology Co., Ltd. (CN)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Agrolic Impex (UZ)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Sepidan Osareh (IR)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 F&C Licorice (IS)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Norevo GmbH (DE)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Ransom Naturals (UK)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Zagros Licorice (IR)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Mafco Worldwide (US)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Maruzen Pharmaceuticals (JP)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Aushadhi Herbal (IN)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 VPL Chemicals (IN)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Glycyrrhiza Inflata Root Extract market?
The global Glycyrrhiza Inflata Root Extract market is estimated at US$ 254 million in 2025 (base year) and is projected to reach US$ 391 million by 2032.
What is the forecast CAGR for the Glycyrrhiza Inflata Root Extract market?
The market is expected to grow at a CAGR of 6.5% from 2026 to 2032, expanding from US$ 254 million in 2025 to US$ 391 million in 2032, roughly 1.5 times its base-year value.
What is Glycyrrhiza Inflata Root Extract?
In 2025, global sales volume of Glycyrrhiza inflata root extract reached 12,000 metric tons, with an average price of US$20,863 per ton.
What are the main segments of the Glycyrrhiza Inflata Root Extract market by type?
By type, the market is segmented into Pharmaceutical Grade, Food Grade, Feed Grade and Others.
Which applications drive demand in the Glycyrrhiza Inflata Root Extract market?
Key applications covered include Food Industry, Cosmetic Industry, Pharmaceutical Industry and Others.
Who are the key players in the Glycyrrhiza Inflata Root Extract market?
Key players profiled include Xinjiang Long Hui Yuan Pharmaceutical Co., Ltd. (CN), Qinghai Beili Licorice Science and Technology Co., Ltd. (CN), Gansu Fanzhi Pharmaceutical Co., Ltd. (CN), Zhangjiagang Free Trade Zone Hongyufeng Biotechnology Co., Ltd. (CN), Agrolic Impex (UZ), Sepidan Osareh (IR), F&C Licorice (IS) and Norevo GmbH (DE), among 14 companies covered in total.
Which regions and countries are covered for Glycyrrhiza Inflata Root Extract?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Glycyrrhiza Inflata Root Extract market?
What factors are driving Glycyrrhiza Inflata Root Extract market growth, globally and by region?
What challenges does the Glycyrrhiza Inflata Root Extract market face?
Large-scale cultivation dedicated specifically to Glycyrrhiza inflata remains limited, and the stability of raw material supply is a critical bottleneck constraining the expansion of production capacity.
Who should buy the Glycyrrhiza Inflata Root Extract market report?
The report is intended for manufacturers and solution providers, distributors and end users in Food Industry, Cosmetic Industry and Pharmaceutical Industry, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Glycyrrhiza Inflata Root Extract market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.